Brief: Aroa Biosurgery Says Total Revenue Guidance For FY23 Of NZ$62-64 Million
25/10/2022 24:00
Oct 25 (Reuters) - Aroa Biosurgery Ltd ARX.AX :
* TOTAL REVENUE GUIDANCE FOR FY23 OF NZ$62-64 MILLION
* FY23 NORMALISED EBITDA EXPECTED TO BE APPROXIMATELY
BREAKEVEN
* H1 FY23 PRODUCT REVENUE (UNAUDITED) GREW 44% TO NZ$28.8
MILLION
Source text for Eikon: ID:nASX1rm8cs
Further company coverage: ARX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aroa Biosurgery
See all newsAustralia-listed Aroa Biosurgery climbs as annual earnings beat guidance
Brief: Aroa Biosurgery Posts Adjusted EBITDA Of NZ$12.6 Million
Aroa Biosurgery climbs as prelim annual results beat outlook
Brief: Aroa Biosurgery Posts FY26 Prelim Total Revenue Of NZ$104 Million
Brief: Aroa Biosurgery Says Expects FY26 Revenue At Upper End Of NZ$92-100 Million